QR-Code

Gantenerumab for Early Alzheimer's Disease: An Updated Systematic Review and Meta‐Analysis

ABSTRACT Introduction Alzheimer's disease (AD) is a progressive neurodegenerative disorder with limited treatment options. Gantenerumab, a β‐amyloid–targeting monoclonal antibody, has shown mixed clinical results. With new trial data available, this updated systematic review and meta‐analysis re‐eva...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Muhammad Nouman Javed, Saim Mahmood Khan, Smaher Mustafa, Amna Mujtaba, Hassaan Amin, Naveen Azhar, Abdullah Hameed, Alaa Zayed, Maliha Khalid, Jawairya Muhammad Hussain
Format: Artigo
Sprache:Inglês
Veröffentlicht: Wiley 2026-08-01
Schriftenreihe:Brain and Behavior
Schlagworte:
early Alzheimer's disease
gantenerumab
monoclonal antibody
amyloid
Online-Zugang:https://doi.org/10.1002/brb3.71643
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge